NASDAQ:AXGN - AxoGen Stock Price, Price Target & More

$40.65 +0.95 (+2.39 %)

(As of 04/19/2018 09:30 AM ET)

Previous Close$39.70

Today's Range$39.45 - $40.70

52-Week Range$11.30 - $40.95

Volume258,700 shs

Average Volume336,327 shs

Market Capitalization$1.37 billion

P/E Ratio-131.13

Dividend YieldN/A

Beta0.01

About AxoGen (NASDAQ:AXGN)

AxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company's surgical solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Receive AXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

SymbolNASDAQ:AXGN

CUSIPN/A

Webwww.axogeninc.com

Phone386-462-6800

Debt

Debt-to-Equity Ratio0.79%

Current Ratio4.07%

Quick Ratio3.53%

Price-To-Earnings

Trailing P/E Ratio-131.13

Forward P/E Ratio-135.50

P/E GrowthN/A

Sales & Book Value

Annual Sales$60.43 million

Price / Sales23.25

Cash FlowN/A

Price / CashN/A

Book Value$0.74 per share

Price / Book54.93

Profitability

EPS (Most Recent Fiscal Year)($0.31)

Net Income$-10,440,000.00

Net Margins-17.29%

Return on Equity-70.63%

Return on Assets-22.33%

Miscellaneous

Employees199

Outstanding Shares34,560,000

How to Become a New Pot Stock Millionaire

AxoGen (NASDAQ:AXGN) Frequently Asked Questions

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc (NASDAQ:AXGN) issued its earnings results on Wednesday, February, 28th. The medical equipment provider reported ($0.07) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.09) by $0.02. The medical equipment provider had revenue of $16.97 million for the quarter, compared to analysts' expectations of $16.38 million. AxoGen had a negative return on equity of 70.63% and a negative net margin of 17.29%. The business's revenue was up 48.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) earnings per share. View AxoGen's Earnings History.

What price target have analysts set for AXGN?

8 brokerages have issued 1-year price targets for AxoGen's stock. Their predictions range from $21.00 to $45.00. On average, they expect AxoGen's share price to reach $33.1429 in the next twelve months. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Some companies that are related to AxoGen include CONMED (CNMD), NxStage (NXTM), Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Zynex (ZYXI), Biolife Solutions (BLFS), Viveve Medical (VIVE), Second Sight Medical (EYES), Edap Tms (EDAP), IRIDEX (IRIX), BioSig Technologies (BSGM), Soleno Therapeutics (SLNO), Digirad (DRAD) and Aradigm (ARDM).

Who are AxoGen's key executives?

AxoGen's management team includes the folowing people:

Ms. Karen Zaderej, Pres, CEO & Director (Age 56)
Mr. Peter J. Mariani, CFO & Principal Accounting Officer (Age 54)
Mr. Gregory G. Freitag, Gen. Counsel, Sr. VP of Bus. Devel. & Director (Age 56)
Mr. Shawn F. McCarrey, Sr. VP of Sales (Age 60)
Mr. Jon S. Gingrich, Chief Commercial Officer (Age 49)

Has AxoGen been receiving favorable news coverage?

News coverage about AXGN stock has trended positive on Thursday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. AxoGen earned a news sentiment score of 0.30 on Accern's scale. They also gave media coverage about the medical equipment provider an impact score of 44.14 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of AxoGen?

Shares of AXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AxoGen's stock price today?

One share of AXGN stock can currently be purchased for approximately $40.65.

How big of a company is AxoGen?

AxoGen has a market capitalization of $1.37 billion and generates $60.43 million in revenue each year. The medical equipment provider earns $-10,440,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. AxoGen employs 199 workers across the globe.

How can I contact AxoGen?

AxoGen's mailing address is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-462-6800 or via email at [email protected]

MarketBeat Community Rating for AxoGen (AXGN)

Community Ranking:		3.4 out of 5 ( )
Outperform Votes:		182 (Vote Outperform)
Underperform Votes:		88 (Vote Underperform)
Total Votes:		270

MarketBeat's community ratings are surveys of what our community members think about AxoGen and other stocks. Vote "Outperform" if you believe AXGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXGN will underperform the S&P 500 over the long term. You may vote once every thirty days.

AxoGen (NASDAQ:AXGN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

8 Wall Street analysts have issued ratings and price targets for AxoGen in the last 12 months. Their average twelve-month price target is $33.1429, suggesting that the stock has a possible downside of 18.47%. The high price target for AXGN is $45.00 and the low price target for AXGN is $21.00. There are currently 8 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	3.00	3.00	3.00	3.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$33.1429	$33.1429	$29.3333	$17.40
Price Target Upside:	18.47% downside	11.97% downside	5.53% downside	10.08% downside

AxoGen (NASDAQ:AXGN) Consensus Price Target History

Price Target History for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/19/2018	Jefferies Group	Boost Price Target	Buy	$45.00	Medium
3/2/2018	Lake Street Capital	Set Price Target	Buy -> Buy	$26.00 -> $38.00	Medium
3/1/2018	JMP Securities	Boost Price Target	Market Outperform	$27.00 -> $34.00	High
2/5/2018	William Blair	Initiated Coverage	Outperform		High
1/8/2018	Cantor Fitzgerald	Set Price Target	Buy	$37.00	High
11/21/2017	Leerink Swann	Boost Price Target	Outperform -> Outperform	$26.00 -> $30.00	N/A
11/21/2017	Wedbush	Reiterated Rating	Buy	$22.00 -> $27.00	N/A
9/12/2017	Roth Capital	Reiterated Rating	Buy	$18.00 -> $21.00	Low

(Data available from 4/19/2016 forward)

AxoGen (NASDAQ:AXGN) Earnings History and Estimates Chart

Earnings by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) Earnings Estimates

2018 EPS Consensus Estimate: ($0.21)
2019 EPS Consensus Estimate: ($0.09)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	($0.15)	$0.01	($0.08)
Q2 2018	4	($0.08)	$0.03	($0.03)
Q3 2018	4	($0.08)	$0.04	($0.03)
Q4 2018	3	($0.09)	($0.05)	($0.07)
Q1 2019	2	($0.04)	($0.04)	($0.04)
Q2 2019	2	($0.04)	($0.04)	($0.04)
Q3 2019	2	($0.04)	($0.02)	($0.03)
Q4 2019	1	$0.02	$0.02	$0.02

AxoGen (NASDAQ AXGN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
2/28/2018	Q4 2017	($0.09)	($0.07)	$16.38 million	$16.97 million	View	Listen
11/1/2017	Q3 2017	($0.06)	($0.06)	$15.55 million	$16.05 million	View	N/A
8/2/2017	Q2 2017	($0.08)	($0.06)	$14.40 million	$15.20 million	View	Listen
5/4/2017	Q1 2017	($0.10)	($0.11)	$11.83 million	$12.24 million	View	Listen
2/22/2017	Q4 2016	($0.09)	($0.10)		$11.41 million	View	Listen
11/2/2016	Q3 2016	($0.08)	($0.08)	$11.21 million	$11.21 million	View	N/A
8/3/2016	Q2	($0.12)	($0.09)	$9.28 million	$10.38 million	View	N/A
5/4/2016	Q1 2016	($0.13)	($0.12)	$7.74 million	$8.11 million	View	N/A
2/29/2016	Q4 2015	($0.11)	($0.12)	$7.13 million	$7.81 million	View	N/A
11/5/2015	Q3 2015	($0.12)	($0.11)	$6.70 million	$8.15 million	View	N/A
8/6/2015	Q2 2015	($0.15)	($0.13)	$5.89 million	$6.42 million	View	N/A
5/5/2015	Q1 2015	($0.17)	($0.16)	$4.90 million	$4.95 million	View	N/A
3/5/2015	Q4 2014	($0.18)	($0.36)	$4.74 million	$4.79 million	View	N/A
11/13/2014	Q3 2014	($0.24)	($0.19)		$4.67 million	View	N/A
8/4/2014	Q2 2014	($0.22)	($0.21)	$3.30 million	$4.21 million	View	N/A
4/30/2014	Q1 2014	($0.26)	($0.24)	$2.75 million	$3.14 million	View	N/A
3/6/2014		($0.22)	($0.24)	$3.17 million	$2.99 million	View	N/A
10/30/2013	Q3 2013	($0.20)	($0.25)	$3.07 million	$2.96 million	View	N/A
8/14/2013	Q2 2013		($0.31)	$2.86 million	$2.86 million	View	N/A
4/30/2013	Q1 2013	($0.26)	($0.31)	$2.53 million	$2.14 million	View	N/A
3/12/2013	Q4 2012	($0.23)	($0.36)			View	N/A
11/7/2012	Q3 2012	($0.17)	($0.20)			View	N/A
8/14/2012	Q2 2012	($0.19)	($0.15)			View	N/A
5/14/2012	Q1 2012	($0.19)	($0.19)			View	N/A
11/9/2011	Q3 2011		($2.60)			View	N/A
8/11/2011	Q2 2011		$0.06			View	N/A
5/17/2011	Q1 2011		$0.21			View	N/A
3/30/2011	Q4 2010		($0.09)			View	N/A
11/15/2010	Q3 2010		($0.11)			View	N/A
8/16/2010	Q2 2010		($0.05)			View	N/A
5/17/2010	Q1 2010		($0.06)			View	N/A
3/31/2009	Q4 2008		($0.02)			View	N/A

(Earnings results data provided by Zacks Investment Research)

AxoGen (NASDAQ:AXGN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

AxoGen (NASDAQ AXGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.86%
Institutional Ownership Percentage: 67.78%

Insider Trading History for AxoGen (NASDAQ:AXGN)

Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ AXGN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/20/2018	Jamie Mark Grooms	Director	Sell	63,395	$27.67	$1,754,139.65	5,827
2/15/2018	Jamie Mark Grooms	CFO	Sell	95,712	$26.84	$2,568,910.08
2/13/2018	Jamie Mark Grooms	CFO	Sell	10,300	$26.21	$269,963.00
12/12/2017	Jamie Mark Grooms	Director	Sell	38,405	$26.35	$1,011,971.75
12/8/2017	Jamie Mark Grooms	Director	Sell	84,295	$26.38	$2,223,702.10
12/6/2017	Jamie Mark Grooms	Director	Sell	21,290	$26.22	$558,223.80
11/20/2017	Guido J Neels	Director	Sell	1,150,000	$19.74	$22,701,000.00
9/11/2017	Robert James Rudelius	Director	Sell	16,143	$18.00	$290,574.00	43,273
10/7/2016	Amy Mcbride Wendell	Director	Buy	13,333	$7.50	$99,997.50	13,333
10/7/2016	John P Engels	VP	Buy	4,000	$7.50	$30,000.00	98,425
10/7/2016	Karen L Zaderej	CEO	Buy	10,000	$7.50	$75,000.00	242,147
10/7/2016	Peter J Mariani	CFO	Buy	3,333	$7.50	$24,997.50	3,333
8/9/2016	Joseph M Mandato	Director	Sell	149,618	$8.54	$1,277,737.72
8/8/2016	Joseph M Mandato	Director	Sell	107,450	$8.63	$927,293.50
7/21/2016	James E Flynn	Insider	Sell	102,136	$6.70	$684,311.20
7/18/2016	James E Flynn	Insider	Sell	279,303	$7.53	$2,103,151.59
9/18/2015	James E Flynn	Insider	Sell	345,000	$5.50	$1,897,500.00
6/3/2015	Joseph M Mandato	Director	Buy	6,500	$3.10	$20,150.00
6/2/2015	Lee Robert Johnston Jr	Insider	Buy	5,000	$3.06	$15,300.00
4/8/2015	James E Flynn	Insider	Sell	144,385	$3.25	$469,251.25
12/10/2014	Lee Robert Johnston Jr	CFO	Buy	10,000	$3.06	$30,600.00
8/12/2014	Mark Stephen Gold	Director	Buy	20,000	$2.29	$45,800.00
8/8/2014	Mark Stephen Gold	Director	Buy	11,000	$2.31	$25,410.00
6/6/2014	Lee Robert Johnston Jr	CFO	Buy	10,000	$2.58	$25,800.00
6/3/2014	Gregory Gene Freitag	CFO	Buy	5,200	$2.45	$12,740.00
6/3/2014	Karen L Zaderej	CEO	Buy	5,000	$2.43	$12,150.00
5/20/2014	Jill F Schiaparelli	SVP	Buy	2,000	$2.63	$5,260.00
5/12/2014	Karen L Zaderej	CEO	Buy	5,000	$2.70	$13,500.00
5/7/2014	Mark Stephen Gold	Director	Buy	1,977	$2.60	$5,140.20
3/13/2014	Karen L Zaderej	CEO	Buy	1,500	$3.49	$5,235.00
8/29/2013	Shawn F Mccarrey	SVP	Buy	25,000	$3.21	$80,250.00
8/24/2013	Shawn F Mccarrey	SVP	Buy	5,000	$3.00	$15,000.00
8/14/2013	Jill F Schiaparelli	SVP	Buy	5,000	$3.00	$15,000.00
8/14/2013	John Frederick Harper	Director	Buy	66,666	$3.00	$199,998.00
8/14/2013	Karen L Zaderej	CEO	Buy	8,334	$3.00	$25,002.00
12/4/2012	Jill F Schiaparelli	SVP	Buy	2,000	$2.55	$5,100.00
11/29/2012	Jill F Schiaparelli	SVP	Buy	1,000	$2.70	$2,700.00
11/15/2012	Jill F Schiaparelli	SVP	Buy	2,750	$2.56	$7,040.00
10/1/2012	John Frederick Harper	Director	Buy	86,557	$3.61	$312,470.77

(Data available from 1/1/2013 forward)

AxoGen (NASDAQ AXGN) News Headlines

Source:

Date	Headline
	AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018 finance.yahoo.com - April 18 at 9:29 AM
	AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018 feeds.benzinga.com - April 18 at 7:52 AM
	Zacks: Brokerages Expect AxoGen, Inc (AXGN) Will Post Quarterly Sales of $17.21 Million www.americanbankingnews.com - April 18 at 3:58 AM
	AxoGen, Inc (AXGN) Expected to Announce Earnings of -$0.11 Per Share www.americanbankingnews.com - April 16 at 9:21 AM
	AxoGen (AXGN) Receives New Coverage from Analysts at Leerink Swann www.americanbankingnews.com - April 15 at 9:45 AM
	AxoGen (AXGN) Lowered to Hold at BidaskClub www.americanbankingnews.com - April 13 at 4:55 PM
	AxoGen Offers An Exciting Story At Nosebleed Prices seekingalpha.com - April 12 at 4:26 PM
	AxoGen, Inc. Announces 2018 Annual Shareholders' Meeting globenewswire.com - April 12 at 10:21 AM
	AxoGen (AXGN) and Sonova (SONVY) Financial Comparison www.americanbankingnews.com - April 10 at 11:31 PM
	Comparing AxoGen (AXGN) and Its Competitors www.americanbankingnews.com - April 10 at 9:15 AM
	Head-To-Head Comparison: AxoGen (AXGN) vs. Its Rivals www.americanbankingnews.com - April 9 at 11:18 PM
	Analyzing AxoGen (AXGN) and The Competition www.americanbankingnews.com - April 6 at 5:13 PM
	AxoGen (AXGN) and Its Rivals Financial Survey www.americanbankingnews.com - April 4 at 11:47 AM
	AxoGen (AXGN) Price Target Raised to $26.00 at Leerink Swann www.americanbankingnews.com - April 1 at 10:52 PM
	AxoGen, Inc. (AXGN) Given Consensus Rating of "Buy" by Brokerages www.americanbankingnews.com - April 1 at 8:03 AM
	Zacks: Analysts Anticipate AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $17.21 Million www.americanbankingnews.com - April 1 at 4:02 AM
	Brokerages Expect AxoGen, Inc. (AXGN) to Post -$0.11 Earnings Per Share www.americanbankingnews.com - March 30 at 11:28 AM
	AxoGen (AXGN) Downgraded by BidaskClub www.americanbankingnews.com - March 28 at 9:49 PM
	AxoGen (AXGN) Enters Overbought Territory March 27, 2018 www.zacks.com - March 27 at 4:23 PM
	AxoGen (AXGN) Enters Overbought Territory finance.yahoo.com - March 27 at 4:23 PM
	Jefferies Group Increases AxoGen (AXGN) Price Target to $45.00 www.americanbankingnews.com - March 19 at 11:11 AM
	Zacks: Brokerages Expect AxoGen, Inc. (AXGN) Will Announce Earnings of -$0.11 Per Share www.americanbankingnews.com - March 13 at 12:03 PM
	Brokers Issue Forecasts for AxoGen, Inc.'s FY2018 Earnings (AXGN) www.americanbankingnews.com - March 7 at 11:48 AM
	AxoGen, Inc. (AXGN) Receives Consensus Recommendation of "Buy" from Brokerages www.americanbankingnews.com - March 7 at 11:45 AM
	Blog Exposure - Boston Scientific Acquired EMcision for Undisclosed Amount finance.yahoo.com - March 7 at 9:36 AM
	AWM Investment Company Inc. Has $7.97 Million Holdings in AxoGen, Inc. (AXGN) www.americanbankingnews.com - March 6 at 4:44 AM
	Are Earnings Prospects Improving For Loss-Making AxoGen Inc’s (NASDAQ:AXGN)? finance.yahoo.com - March 5 at 5:00 PM
	AxoGen, Inc. (AXGN) Position Lowered by Millrace Asset Group Inc. www.americanbankingnews.com - March 5 at 12:54 PM
	Q3 2018 Earnings Estimate for AxoGen, Inc. Issued By William Blair (AXGN) www.americanbankingnews.com - March 5 at 4:30 AM
	Q1 2018 EPS Estimates for AxoGen, Inc. Reduced by Leerink Swann (AXGN) www.americanbankingnews.com - March 5 at 2:56 AM
	Jefferies Group Comments on AxoGen, Inc.'s Q1 2018 Earnings (AXGN) www.americanbankingnews.com - March 5 at 2:56 AM
	Contrasting Zynex (ZYXI) & AxoGen (AXGN) www.americanbankingnews.com - March 4 at 12:02 PM
	AxoGen Inc. (AXGN) Has Broken Out To A New High On Q4 Results - Nasdaq www.nasdaq.com - March 3 at 5:09 PM
	AxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript - Motley Fool www.fool.com - March 3 at 5:09 PM
	AxoGen (AXGN) PT Set at $38.00 by Lake Street Capital www.americanbankingnews.com - March 2 at 7:48 PM
	AxoGen, Inc. (AXGN) is Next Century Growth Investors LLC's 5th Largest Position www.americanbankingnews.com - March 2 at 5:58 PM
	Brokers Offer Predictions for AxoGen, Inc.'s FY2020 Earnings (AXGN) www.americanbankingnews.com - March 2 at 5:10 PM
	AxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript finance.yahoo.com - March 2 at 5:05 PM
	AxoGen (AXGN) PT Raised to $34.00 at JMP Securities www.americanbankingnews.com - March 1 at 7:07 PM
	AxoGen, Inc. (AXGN) Shares Sold by Essex Woodlands Management Inc. www.americanbankingnews.com - March 1 at 2:12 PM
	AxoGen (AXGN) Announces Quarterly Earnings Results www.americanbankingnews.com - February 28 at 9:20 PM
	BRIEF-Axogen Inc Q4 Adjusted Loss Per Share $0.07 www.reuters.com - February 28 at 4:59 PM
	AxoGen, Inc. to Host Earnings Call finance.yahoo.com - February 28 at 4:59 PM
	AxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial Results finance.yahoo.com - February 28 at 4:59 PM
	EAM Investors LLC Sells 73,412 Shares of AxoGen, Inc. (AXGN) www.americanbankingnews.com - February 27 at 3:00 PM
	AxoGen, Inc. (AXGN) Position Cut by Cortina Asset Management LLC www.americanbankingnews.com - February 27 at 1:40 PM
	AxoGen, Inc. to Present at 30th Annual ROTH Conference finance.yahoo.com - February 27 at 9:30 AM
	AxoGen Named Employee Engagement Best Practices Award Winner by DecisionWise International finance.yahoo.com - February 27 at 9:30 AM
	Zacks: Analysts Anticipate AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $16.09 Million www.americanbankingnews.com - February 26 at 4:38 AM
	BidaskClub Upgrades AxoGen (AXGN) to "Strong-Buy" www.americanbankingnews.com - February 25 at 12:00 AM

AxoGen (NASDAQ:AXGN) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

AxoGen (NASDAQ:AXGN) Income Statement, Balance Sheet and Cash Flow Statement

AxoGen (NASDAQ AXGN) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff